Heart attacks in women can involve unusual tiredness, shortness of breath, nausea or pain outside the chest. These symptoms ...

The designation gives HeartBeam prioritized FDA interaction as it prepares a pivotal study of its 3D ECG technology for ...

The FDA's Breakthrough Device Program is intended to speed the development and review of technologies that may provide more effective diagnosis or treatment of life-threatening conditions. The ...

HeartBeam, Inc. (NASDAQ: BEAT) announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to the HeartBeam System for assessing potential heart ...

HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study HeartBeam’s technology uniquely capable of assessing possible heart attacks outside of traditional clinical settings ...

On World Heart Day, an expert explains heart attack symptoms, family history risks, preventive check-ups and emergency ...

HeartBeam (BEAT) completed enrollment ahead of its target timeline in the ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection, the company said Tuesday. The study enrolled ...

Patients with suspected heart attacks across west Georgia and east Alabama will now have access to artificial intelligence-powered electrocardiogram (ECG) assessment whether their first medical ...

Heart Health Tips: Heart attack, cardiac arrest and heart failure are terms that are sometimes used interchangeably in ...

Accelerated enrollment completion in ALIGN-ACS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection Data analysis is underway, with full results anticipated ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. HeartBeam’s technology uniquely capable of assessing ...

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS ...